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Abstract
Background: The pathogenesis of obesity is reportedly related to variations in the fat mass and an obesity-
associated gene (FTO); however, as the number of reports increases, particularly with respect to varying ethnicities,
there is a need to determine more precisely the effect sizes in each ethnic group. In addition, some reports have
claimed ethnic-specific associations with alternative SNPs, and to that end there has been a degree of confusion.
Methods: We searched PubMed, MEDLINE, Web of Science, EMBASE, and BIOSIS Preview to identify studies
investigating the associations between the five polymorphisms and obesity risk. Individual study odds ratios (OR)
and their 95% confidence intervals (CI) were estimated using per-allele comparison. Summary ORs were estimated
using a random effects model.
Results: We identified 59 eligible case-control studies in 27 articles, investigating 41,734 obesity cases and 69,837
healthy controls. Significant associations were detected between obesity risk and the five polymorphisms:
rs9939609 (OR: 1.31, 95% CI: 1.26 to 1.36), rs1421085 (OR: 1.43, 95% CI: 1.33 to 1.53), rs8050136 (OR: 1.25, 95% CI:
1.13 to 1.38), rs17817449 (OR: 1.54, 95% CI: 1.41 to 1.68), and rs1121980 (OR: 1.34, 95% CI: 1.10 to 1.62). Begg’s and
Egger’s tests provided no evidence of publication bias for the polymorphisms except rs1121980. There is evidence
of higher heterogeneity, with I
2 test values ranging from 38.1% to 84.5%.
Conclusions: This meta-analysis suggests that FTO may represent a low-penetrance susceptible gene for obesity
risk. Individual studies with large sample size are needed to further evaluate the associations between the
polymorphisms and obesity risk in various ethnic populations.
Background
Obesity is becoming a worldwide epidemic in modern
society. It is prevalent in individuals of both genders and
of all ages, socio-economic strata, and ethnic groups. It is
estimated that the total number of overweight adults has
reached more than 1.1 billion worldwide, including 312
million obese individuals and that about 10% of children
are classified as overweight or obese [1,2]. The worldwide
obesity epidemic is mainly caused by environmental fac-
tors, including excessive food intake and a lack of physi-
cal activity [3]. Obesity may lead to cardiovascular
disease, type 2 diabetes, and several cancers. Overweight
and inactivity account for an estimated one-quarter to a
one-third of cancers of the breast, colon, endometrium,
kidney, and esophagus [2].
In 2007, FTO (fat mass and obesity-associated gene)
was first discovered in a genome-wide association study
(GWAS) for type 2 diabetes [4], and, almost simulta-
neously, two other teams independently reported that
the FTO gene was associated with obesity (or obesity-
related traits) in a GWAS and a genetic association
study [5,6]. The FTO gene, which is located on chromo-
some 16q12.2 and has nine exons, is strongly conserved
across various vertebrate species (for example, fish and
chicken) and emerged 450 million years ago [7]. FTO is
mainly expressed in the hypothalamus and encodes a
2-oxoglutarate-dependent nucleic acid demethylase. It
may play important roles in the management of energy
homeostasis [7,8], nucleic acid demethylation, and the
regulation of body fat masses by lipolysis [9].
The FTO gene has recently attracted much attention
in obesity research. Previous genetic association-based
studies have shown that SNPs in the FTO gene are asso-
ciated with increased body mass index (BMI) [5,10,11],
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fasting insulin [12], glucose [12], triglycerides [12], lower
HDL cholesterol [12], waist circumference [11,13], and
weight [5]. For example, Scuteri et al.[ 5 ]s h o w e dt h a t
SNP rs9930506 within FTO was associated with BMI,
total body weight, and hip circumference; many variants
have been reported to be associated with obesity, includ-
ing rs9939609, rs1421085, rs8050136, rs17817449, and
rs1121980. These single nucleotide polymorphisms
(SNPs) lie within a 47-kilobase linkage disequilibrium
(LD) block encompassing parts of the first two introns
and exon 2 of FTO. The transcriptional start site of the
retinitis pigmentosa GTPase regulator-interacting pro-
tein 1-like (RPGRIP1L) gene is also near the 5’ end of
FTO [4]. Based on this observation, Fawcett et al. [14]
argued that the association signal could be due to a cor-
relation between FTO intronic SNPs and RPGRIP1L.
Of the SNPs that were reported to associate with
obesity, rs9939609 has been of particular interest since
it was discovered by Frayling et al.[ 4 ]T h ea s s o c i a t i o n s
of other SNPs in the FTO gene with obesity (or over-
weight) have been replicated in large European popula-
tions [5,6]. In some different ethnic groups, however,
such as the Chinese [15] and Oceanic populations [16],
no association was observed between rs9939609 and
obesity by either genetic association studies or GWAS.
However, as more studies are reported, particularly
with respect to various ethnicities, there is a need to
determine more precisely the effect sizes in each major
racial group and to investigate the minor allele fre-
quency (MAF) and the LD patterns of the SNPs across
different ethnicities. In addition, some reports have
claimed ethnic-specific associations with alternative
SNPs, and to that end there has been a degree of con-
fusion. Therefore, we conducted meta-analyses of all
available data.
Methods
Publication search
We searched PubMed, MEDLINE, Web of Science,
EMBASE, and BIOSIS Preview up to October 2010 for
studies concerning the association between FTO poly-
morphisms and obesity (or obesity-related traits includ-
ing body weight, leptin levels, subcutaneous fat, fat
mass, hip and waist circumference, lean mass, body
height, and BMI). There are no limits on language. Two
search themes were combined using the Boolean opera-
tor “and”.T h ef i r s tt h e m ew a s( ”obesity“ (Mesh) OR
“overweight“ (Mesh) OR “body mass index” (Mesh) OR
“obesity, morbid“ (Mesh) OR “morbid obesity“ OR “mor-
bid obesities“ OR “BMI“ OR “body weight“ OR “leptin
levels“ OR “subcutaneous fatness“ OR “fat mass“ OR
“hip circumference“ OR “waist circumference“ OR “lean
mass“ OR “body height“). The second theme was
(”rs9939609“ OR “rs8050136“ OR “rs1421085“ OR
“rs17817449“ OR “rs1121980“ OR “FTO“ OR “FTO pro-
tein, human“ (Substance Name) OR “fat mass and obe-
sity associated“ (Substance Name)). Meta-analysis
articles were not excluded because several original stu-
dies were often combined in meta-analysis articles on
genetic association studies.
Selection
Genetic association studies and GWASs with case-con-
trol subjects in which the case subjects were obese and
the control subjects were healthy were included. At least
two studies had to be available for each SNP. Studies
were excluded if the control subjects violated the
Hardy-Weinberg Equilibrium (HWE).
Data extraction
Two reviewers (SHP and YMZ) independently searched
the databases. The search results were then evaluated by
f i v er e v i e w e r s( S H P ,Y M Z ,F Y X ,X B R ,a n dX B L ) .D i s -
agreements were resolved by discussions among the
reviewers. Information on gender, author name, country,
ethnicity, year of publication, mean age of examination,
mean BMI (calculated as weight in kilograms divided by
height in meters squared), and genotypes (for example,
TT/TA/AA) were retrieved. MAF and P-values of the
HWE were calculated from the above genotype data.
Adult individuals with BMI ≥30 kg/m
2 were defined as
case subjects of obesity, and individuals with BMI <30
kg/m
2 were considered control subjects. The criteria for
childhood obesity described by Cole et al. [17] were
adopted.
Statistical analysis
To maximize the number of studies included, analyses
were conducted by calculating the ORs under per-allele
comparison. We found that an additive genetic model
was always employed in most of the genetic association
studies concerning the association between FTO and
obesity risk. Therefore, the overall effects were also cal-
culated in an additive genetic model in this meta-analy-
sis. For comparison, the ORs in dominant and recessive
genetic models were also calculated. Recently, Zintzaras
[18] reported a novel method to calculate the general-
ized odds ratio (ORG), which may overcome the short-
comings of multiple model testing or erroneous model
specification. Thus, the ORG calculations were also
performed.
All statistical tests were performed with Stata 10.0
software (Stata, College Station, TX, USA). The effect
sizes were calculated by the DerSimonian-Laird method,
which is a random effect model because a modest or
higher heterogeneous status was found in both allelic
comparison and additive genetic models.
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2 test (Q test) was used to evaluate
heterogeneity between studies, and a threshold P-value of
0.1 was considered statistically significant. The I
2 test was
also conducted to evaluate heterogeneity between studies
[19]. Begg’s and Egger’s tests were both used to test the
significance of the publication bias, with a P-value < 0.1
considered as significant. We used the software developed
by Guo et al. [20] to test (using exact test [21]) the signif-
icance of the HWE in control subjects, with a threshold
P-value of 0.05 and 0.001 considered statistically signif-
icant for candidate gene association studies and GWAS
[22,23], respectively. Heterogeneity is considered higher
when I
2 >50% and much higher when I
2 >75% [24], and
higher heterogeneity is a common phenomenon in
genetic association studies [25,26]. To estimate hetero-
geneity, meta-regression was performed with the mean
age of control subjects (Age_Control) and the mean
BMI of control subjects (BMI_Control) as the covari-
ates [27].
Analyses of sensitivity, subgroup, and LD pattern
To identify the source of the heterogeneity between stu-
dies, we performed sensitivity analyses by including and
excluding some studies. Sensitivity analyses were done
sequentially for all of the SNPs and all of the studies (or
by some subgroups of the studies).
We sub-grouped the studies into six groups (Cauca-
sian, Asian, Hispanic, African, South American, and
Mixed) on rs9939609, four groups (Caucasian, Asian,
African, and Mixed) on rs8050136, and two groups
(Caucasian, Asian) on rs1121980.
The LD patterns of the SNPs were investigated using
the HapMap Database (http://hapmap.ncbi.nlm.nih.gov/)
and HaploView software (Whitehead Institute for Bio-
medical Research, Cambridge, USA) [28].
Results
Characteristics of the included studies
According to the search strategy, 170, 142, 160, 167, and
171 articles (a total of 810 articles) were retrieved from
PubMed, MEDLINE, Web of Science, EMBASE, and
BIOSIS Preview, respectively. After the first screening, in
which the abstracts or titles were read, 753 articles were
excluded, and 59 articles underwent further review. After
reviewing these articles, 30 additional articles were
excluded, which left a total of 27 articles for inclusion in
this meta-analysis. According to the PRISMA guidelines
[29], the flow diagram is shown in Figure 1. A total of 21
articles [4,15,30-48] included 30 studies on rs9939609;
five articles [6,33,41,49,50] included eleven studies on
rs1421085; seven articles [15,30,31,43,46,51,52] included
nine studies on; rs8050136, two articles [6,33] included
six studies on rs17817449; and three articles [37,43,53]
included three studies on rs1121980. Not counting the
overlapping literature, 27 articles were obtained (Figure
1). In the 30 studies concerning rs9939609, subgroup
analyses were performed. The 30 studies were divided
into six subgroups according to ethnicity, as follows: stu-
dies with Caucasian populations [4,33,36,41-45,47], Asian
populations [15,31,32,35,37,46,48], Hispanic groups
[31,38,39], South American [40], African [31], and studies
using mixed ethnic populations [34]. In all of the
included studies, the genotype distributions in the
control subjects are consistent with the HWE. Three stu-
dies by Song et al. [31] (concerning rs9939609 and
rs8050136) and one study by Price et al.[ 3 3 ]w e r e
excluded due to the deviation from the HWE (with a P-
value of less than 0.05).
Unfortunately, some articles were excluded because
the associations were between one or more SNPs and
obesity-related traits rather than obesity itself (for exam-
ple, ref. [5,10,11,16,54,55]). There are five included arti-
cles [15,34,51-53] with OR values and other detailed
information but without genotype data. We attempted
to obtain the genotyped data from these studies by e-
mail, but we received no response from the authors.
The clinical characteristics of the included studies are
shown in Table 1. The genotype data, as well as the
ORs under both per-allele comparisons and the additive
genetic model, are shown in Table 2. The ORs under
dominant and recessive genetic models and the ORG are
shown in Table S1 (see Additional file 1). These studies
were published between 2007 and 2010. A total of 59
studies relating to all five SNPs were included, involving
a total of 41,734 obesity cases and 69,837 healthy
controls.
We estimated the MAF in the five polymorphisms
from the control subjects of all studies identified for
inclusion in the present meta-analysis. Across all studies,
the MAFs ranged between 11% and 45%, 40% and 46%,
11% and 44%, 36% and 60%, and 21% and 44% for
rs9939609, rs1421085, rs8050136, rs17817449, and
rs1121980, respectively.
Meta-analysis of FTO gene SNP rs9939609
Under per-allele comparison, the OR is not available
from the study by Li et al., leaving 29 studies for further
consideration. A total of 21 out of 29 studies reported a
significant, positive association between obesity and the
rs9939609 genotype (Table 2, Figure 2). A significant
association between obesity and rs9939609 was detected,
with an overall OR of 1.31 (95% CI: 1.26 to 1.36) under
per-allele comparison, and there is evidence of heteroge-
neity (I
2 = 44.0%). The Begg’st e s t( P =0 . 3 9 ) ,a n d
Egger’st e s t( P = 0.17) provided no evidence of publica-
tion bias.
When stratifying the data by ethnicity, no evidence of
a significant association was observed in the three
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95% CI: 0.84 to 2.10) under per-allele comparison, with
the largest heterogeneity in all six ethnic groups (I
2 =
85.2%, P = 0.001) (Figure 2). We observed overall ORs
of 1.30 (95% CI: 1.24 to 1.37) and 1.35 (95% CI: 1.27 to
1 . 4 4 )i nt h eC a u c a s i a na n dA s i a ne t h n i cg r o u p sf o r
which more studies had been performed under per-allele
comparison.
By using meta-regression, we detected a significant
correlation between the mean control BMI and effect
size in an allelic comparison (P = 0.03) (see Additional
file 1: Figure S1).
Very similar results were obtained using an additive
genetic model, with an overall OR of 1.31 (95% CI: 1.25
to 1.37) and evidence of heterogeneity (I
2 = 52.8%)
(Table 2, Additional file 1: Figure S2).
Meta-analysis of FTO SNPs rs1421085, rs8050136,
s17817449, and rs1121980
rs1421085
A total of 11 out of 12 studies reported a significant,
positive association between obesity and the rs1421085
genotype (Table 2, Figure 3A). Also under per-allele
comparison, a significant association between obesity
risk and rs1421085 was found (overall OR = 1.43, 95%
CI: 1.33 to 1.53), and there is evidence of heterogeneity
(I
2 =3 8 . 1 % ) .B e g g ’st e s t( P = 0.76) and Egger’st e s t( P =
0.84) provided no evidence of publication bias.
By using meta-regression, no significant correlation
was found between the mean control BMI and effect
size in an allelic comparison (P = 0.50).
rs8050136
Overall, 11 studies have investigated the association of
rs8050136 with obesity. Of the 11 studies, the OR (under
per-allele comparison) of the study by Li et al.i sn o ta v a i l -
able. Of the remaining 10 studies, 5 reported a significant,
positive association between obesity and the rs8050136
genotype (Table 2, Figure 3B). A significant association
between obesity risk and rs8050136 was found (overall OR
= 1.25, 95% CI: 1.13 to 1.38) under per-allele comparison,
and there is evidence of higher heterogeneity (I
2 = 72.0%).
Begg’st e s t( P =1 . 0 )a n dE g g e r ’st e s t( P =0 . 8 7 )p r o v i d e d
no evidence of publication bias.
By using meta-regression, no significant correlation
was found between the mean control BMI and effect
size in an allelic comparison (P = 0.60).
rs17817449
All six of the studies involving rs17817449 reported a
significant, positive association between obesity and
rs17817449 (Table 2, Figure 4A). A significant associa-
tion between obesity risk and rs17817449 was found
(overall OR = 1.54, 95% CI: 1.41 to 1.68) for obesity and
rs17817449 under per-allele comparison, and there is
evidence of higher heterogeneity (I
2 = 45.2%). Begg’s
test (P = 0.85) and Egger’st e s t( P = 0.90) provided no
evidence of publication bias.
By using meta-regression, no significant correlation
was found between the mean control BMI and effect
size in an allelic comparison (P = 0.57).
rs1121980
All three studies reported a significant, positive associa-
tion between obesity and the rs1121980 SNP (Table 2,
Figure 1 Flow diagram of the study selection for the meta-analyses.
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Study Publication
year
Country Ethnicity Case Control
Mean age (SD)
(years)
Mean BMI (SD)
(kg/m
2)
Mean age (SD)
(years)
Mean BMI (SD)
(kg/m
2)
Frayling_a [4]
a 2007 UK Caucasian NA
g NA 28.4 (4.7) 22.7
Frayling_b 2007 UK Caucasian NA NA 31.0 24.4
Frayling_c 2007 UK Caucasian NA NA 40.6 (6.1) 25.6
Frayling_d 2007 UK Caucasian NA NA 56.7 (4.5) 26.4
Frayling_e 2007 UK Caucasian 60.1 (8.8) 32.8 59.7 (9.0) 26.1
Frayling_f 2007 UK Caucasian NA NA 68.8 (5.5) 27.2
Frayling_g 2007 UK Caucasian NA NA 74.3 (6.9) 27.2
Hinney [43]
b 2007 Germany Caucasian 14.4 (3.7) 33.4 (6.8) 26.1 (5.8) 18.3 (1.1)
Dina_a [6] 2007 France Caucasian 44 (12) 47 (7.6) 51 (10) 22.8 (2)
Dina_b 2007 France Caucasian 10.6 (3.5) NA 49 (5.5) 22.3 (2.3)
Dina_c 2007 France Caucasian 11.8 (3.1) 29.8 (5.8) 22.0 (3.7) 21.1 (2.0)
Dina_d 2007 Switzerland Caucasian NA 46.7 (5.5) NA NA
Dina_e 2007 Germany Caucasian 11.6 (2.7) NA 11.7 (1.7) NA
Song_H [31]
c 2007 USA Hispanic NA NA 61.1 (6.71) 30.9 (7.1)
Song_AP 2007 USA Asian NA NA 60.2 (6.77) 29.0 (5.78)
Song_B 2007 USA African NA NA 63.8 (7.58) 24.7 (4.49)
Villalobos [40] 2008 Mexico South American 43.9 (13.1) 39.4 (8.6) NA NA
Chang [35] 2008 China-Taiwan Asian 37.0 (0.56) 38.9 (8.2) 61.1 (0.33) 24.0 (2.9)
Hotta [37] 2008 Japan Asian 49.1 (14.2) 34.5 (5.4) 48.2 (16.5) 21.7 (2.1)
Li [15] 2008 China Asian NA NA 58.6 (6.0) 24.2
Peeters [41] 2008 Belgium Caucasian NA 38.3 (0.3) NA NA
Jacobsson_2008 [42] 2008 Sweden Caucasian 12.6 (3.3) 35.4 (6.6) 17.1 (0.8) 21.1 (2.6)
Muler [44]
d 2008 Germany Caucasian 10.7 (3.1) 28.9 (5.2) 24.6 (2.6) 21.8 (1.1)
Andreasen_a [45] 2008 Denmark Caucasian NA NA 46.2 (7.9) 26.3 (4.6)
Andreasen_b
e 2008 Denmark Caucasian NA NA 60.0 (6.8) 28.6 (4.9)
Andreasen_c 2008 Denmark Caucasian NA NA 58.5 (8.1) 26.5 (4.2)
Grant_C [51] 2008 USA Caucasian 2-18 BMI ≥95th percentile 2-18 BMI<95th percentile
Grant_AA 2008 USA African 2-18 BMI ≥95th percentile 2-18 BMI<95th percentile
Price [33] 2008 USA Caucasian 41.1 (9.4) 49.1 (8.8) 42.6 (8.8) 20.8 (1.8)
Legry [36] 2008 France Caucasian 52.9 (8.2) 33.8 (3.5) 48.9 (8.5) 22.5 (1.8)
Gonzalez [39] 2009 Spain Hispanic 58.0 (11.0) 33.0 (3.3) 54.0 (11.0) 25.8 (2.6)
Zabena [38] 2009 Spain Hispanic 44.8 (12.5) 45.5 (7.4) 45.5 (7.3) 24.3 (2.4)
Tabara [32]
f 2009 Japan Asian NA NA 61.0 (14.0) 23.4 (3.2)
Attaoua [49] 2009 France Caucasian 39.1 (11.4) 39.4 (3.8) 39.6 (11.6) 23.8 (2.6)
Meyre_FC [50] 2009 France Caucasian 11.5 (3.1) 29.0 (9.8) 21.0 (4.5) 20.74 (2.2)
Meyre_FA 2009 France Caucasian 41.1 (10.9) 49.4 (7.8) 49.1 (5.5) 22.3 (2.3)
Meyre_SA 2009 Switzerland Caucasian 42.4 (11.5) 43.7 (7.2) NA NA
Meyre_GC 2009 Germany Caucasian 11.8 (2.9) 29.7 (9.2) 11.8 (2.9) 18.15 (8.1)
Thorleifsson [52] 2009 Mixed Mixed NA NA NA NA
Willer [34] 2009 Mixed Mixed NA NA NA NA
Renstrom [53] 2009 Sweden Caucasian 52.6 (9.5)
h >30 52.6 (9.5)
h 18.5-24.9
Jacobsson_2009 [47] 2009 Sweden Caucasian 50.0 (0) 32.1 (1.9) 50.0 (0) 24.8 (1.8)
Karasawa [48]
f 2010 Japan Asian NA NA 63.0 (1.2) 23.5 (3.2)
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and rs1121980 was found (overall OR = 1.34, 95% CI:
1.10 to 1.62) under per-allele comparison, with evidence
of greater heterogeneity (I
2 = 84.5%). Begg’st e s t( P =
0.12) provided no evidence of publication bias, whereas
the funnel plot (not shown) and Egger’st e s t( P =0 . 0 9 )
showed evidence of publication bias.
By using meta-regression, no significant correlation
was found between the mean control BMI and effect
size in an allelic comparison (P = 0.28).
Discussion
To our knowledge, this meta-analysis is the first one to
investigate the associations between FTO polymorph-
isms and obesity risk across different ethnic groups.
This meta-analysis investigated the associations between
five FTO polymorphisms (rs9939609, rs1421085,
rs8050136, rs17817449, and rs1121980) and obesity risk
in 41,734 cases and 69,837 controls from 59 studies,
counting the cases and control subjects from each study
only once. We found significant evidence for a modest
increase in the risk of obesity associated with the five
polymorphisms in various ethnic populations (Figures 2,
3, 4). However, subgroup analyses showed that in some
ethnic populations, for example, rs9939609 in Hispanic
and African, rs1121980 in Caucasian, and rs8050136 in
Asian and African, significant associations were not
found between the SNPs and obesity risk (see Additional
file 1: Figure S3). These results may be due to the differ-
ences in MAF or LD patterns across different ethnic
populations.
Interestingly, we found that MAF values are very simi-
lar across all five SNPs. For example, the MAFs in the
study by Price et al. are 0.36 for rs9939609 and 0.36 for
rs17817449. There are also ethnic variations of the MAF
in the five polymorphisms. Caucasian, US Hispanics,
and US Africans have higher MAFs (>31%), whereas
Asian populations (for example, Chinese and Japanese)
and South Americans have lower MAFs (between 11%
and 20%). When stratifying the studies on rs9939609
into subgroups, the MAFs are different in various popu-
lations. For example, the MAF in control subjects is
0.34 to 0.44 in Caucasians, 0.11 to 0.20 in Asians, 0.31
to 0.37 in Hispanics, and 0.17 in South Americans, indi-
cating that the MAF in Asian and South American
populations is less than half of that in Caucasian and
Hispanic populations. The population differences in
MAF and LD structure probably have arisen through
evolutionary divergence [56].
For rs9939609, we conducted sensitivity analyses.
After the exclusion of the three children’ss t u d i e s
[42-44], there is a small increase in overall heterogeneity
(I
2 =4 4 . 6 % ,P = 0.008 when exclusion of the three stu-
dies vs. I
2 = 44.0%, P = 0.006 when inclusion of all avail-
able studies) (see Additional file 1: Figure S4). Similarly,
as l i g h ti n c r e a s ei no v e r a l lh e t e r o g e n e i t yw a so b s e r v e d
after the exclusion of the two GWASs [4,43] (I
2 =
51.6%, P = 0.003 with the exclusion of the two studies
vs. I
2 = 44.0%, P = 0.006 with the inclusion of all avail-
able studies). These results indicate that the children’s
studies or GWASs are not the sources of the heteroge-
neity. On the other hand, with the exclusion of the
study by Price et al., the heterogeneity decreased rapidly
(I
2 =0 . 0 % ,P = 0.626 with the exclusion of the study vs.
I
2 = 44.0%, P = 0.006 with the inclusion of all available
studies) in the Caucasian subgroup, indicating that the
study by Price et al. is the main source of heterogeneity
in the Caucasian subgroup. By using an additive genetic
model, coupled with either the inclusion or exclusion of
the study by Li et al., the I
2 value in the heterogeneity
test declined sharply (61.7% vs. 15.6%). Similarly, remov-
ing the study by Chang et al.c a u s e dt h eI
2 value to
increase a little (61.7% vs. 67.0%), suggesting that the
s t u d yb yL iet al. is the main source of heterogeneity in
the Asian ethnic group.
All of the studies on rs1421085 are from Caucasian
populations, but when the five studies were excluded
(two from Switzerland, two from Germany, and one
Table 1 Clinical characteristics of the included studies (Continued)
Liu [46] 2010 China Asian NA NA 58.0 (9.0) 24.5 (3.2)
Cheung [30] 2010 China Asian 46.3 (11.9) 32.2 (4.9) 45.0 (12.5) 21.2 (1.2)
a: The article by Frayling et al. contains seven studies, namely Frayling _a (ALSPAC), Frayling _b (NFBC1966), Frayling _c (Oxford Biobank), Frayling _d (Caerphilly),
Frayling _e (EPIC-Norfolk), Frayling _f (BWHHS), and Frayling _g (InCHIANTI). Please refer to the original article [4] for details.
b: Early-onset, extremely obese cases (mean BMI Z score 4.63 ± 2.27) and healthy, underweight controls (mean BMI Z score -1.38 ± 0.35; BMI <15
thage percentile).
c: The age and BMI values are reported as the mean value of all case and control subjects.
d: Obese cases are reported as the 99.5
th percentile of the median age and gender-specific BMI. Lean controls are reported as the 51.0
st percentile of the median
age and gender-specific BMI.
e: The article by Andreasen et al. contains three studies, including Andreasen_a (Population-based, Inter99 study sample), Andreasen_b
(ADDITION study cohort), and Andreasen_c (SDC control group). For details, please refer to the original article [45].
f: In Japan, obesity is defined as a condition in which the individuals had a BMI ≥25 kg/m
2 according to the guidelines of the Japanese Society for the Study of
obesity [68].
g: Not available.
h: The mean age of all subjects (non-diabetic individuals).
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Page 6 of 15Table 2 Genotypic distributions and ORs for the association between five polymorphisms and obesity
Study N (case/control) OR [95% CI], P-value
Subtotal MAF PHWE 11
a 12 22 Additive model Allelic comparison
rs9939609
Caucasian:
Frayling_a 5,380 (353/5,027) 0.48/0.39 0.513 107/1,879 157/2,407 89/741 1.43 (1.23 to 1.67) 1.43 (1.23 to 1.67)
Frayling_b 3,072 (415/2,657) 0.45/0.37 0.185 132/1,060 193/1,211 90/386 1.36 (1.18 to 1.57) 1.37 (1.18 to 1.59)
Frayling_c 487 (126/361) 0.42/0.38 0.575 45/138 56/175 25/48 1.21 (0.90 to 1.62) 1.21 (0.91 to 1.61)
Frayling_d 623 (200/423) 0.41/0.34 0.447 67/189 101/182 32/52 1.37 (1.07 to 1.75) 1.37 (1.08 to 1.76)
Frayling_e 2,511 (1,588/923) 0.43/0.38 0.625 485/351 847/443 256/129 1.24 (1.10 to 1.40) 1.22 (1.09 to 1.37)
Frayling_f 1,875 (840/1,035) 0.42/0.37 0.547 274/421 427/471 139/143 1.26 (1.10 to 1.44) 1.25 (1.10 to 1.43)
Frayling_g 461 (212/249) 0.47/0.42 0.514 66/82 92/127 54/40 1.25 (0.97 to 1.61) 1.26 (0.97 to 1.63)
Andreasen_a 3,724 (1,045/2,679) 0.45/0.39 0.103 313/993 517/1,309 215/377 1.33 (1.20 to 1.48) 1.32 (1.19 to 1.47)
Andreasen_b 4,671 (2,819/1,852) 0.43/0.39 0.221 911/684 1,385/904 523/264 1.21 (1.11 to 1.31) 1.20 (1.11 to 1.31)
Andreasen_c 377 (104/273) 0.45/0.39 0.076 30/93 55/145 19/35 1.27(0.91 to 1.80) 1.25 (0.90 to 1.72)
Muler 697 (519/178) 0.50/0.44 0.763 140/56 238/86 141/36 1.24 (0.98 to 1.57) 1.26 (0.99 to 1.60)
Price 1,047 (527/520) 0.48/0.36 0.084 152/207 242/257 133/56 1.69 (1.41 to 2.02) 1.69 (1.42 to 2.02)
Peeters 1,367 (1,099/268) 0.46/0.40 0.703 316/94 553/133 230/41 1.28 (1.05 to 1.56) 1.28 (1.05 to 1.55)
Jacobsson_2008 960 (450/510) 0.48/0.42 0.716 133/174 206/244 111/92 1.24 (1.04 to 1.48) 1.25 (1.05 to 1.50)
Legry 3,367 (598/2,769) 0.46/0.41 0.050 171/924 307/1,395 120/450 1.20 (1.05 to 1.36) 1.19 (1.05 to 1.35)
Jacobsson_2009 1,115 (54/1,061) 0.44/0.39 0.218 16/411 29/483 9/167 1.22 (0.83 to 1.80) 1.23 (0.83 to 1.82)
Hinney 926 (484/442) 0.50/0.39 0.690 123/164 241/214 120/64 1.57 (1.30 to 1.90) 1.57 (1.30 to 1.88)
Asian:
Song_AP 240 (77/163) 0.20/0.17 0.409 50/114 23/43 4/6 1.23 (0.76 to 1.97) 1.24 (0.76 to 2.03)
Chang 2,135 (610/1,525) 0.17/0.13 0.355 425/1,158 167/347 18/20 1.38 (1.15 to 1.66) 1.37 (1.14 to 1.5)
Hotta 2,423 (919/1,504) 0.24/0.19 0.393 534/1,005 334/443 51/56 1.37 (1.19 to 1.58) 1.66 (1.31 to 2.11)
Tabara 1,718 (214/1,504) 0.22/0.16 0.438 128/1,063 77/408 9/33 1.54 (1.20 to 1.99) 1.53 (1.19 to 1.95)
Karasawa 2,639 (794/1,845) 0.23/0.20 0.373 477/1,203 271/566 46/76 1.22 (1.06 to 1.41) 1.23 (1.06 to 1.42)
Liu 1,167 (276/891) 0.14/0.11 0.396 201/701 70/181 5/8 1.38 (1.04 to 1.83) 1.36 (1.03 to 1.80)
Li 3,210 (398/2,812) NA/0.12 NA NA NA NA 0.90 (0.70 to 1.15) NA
Hispanic:
Song_H 415 (139/276) 0.27/0.31 0.157 75/138 53/107 11/31 0.85 (0.62 to 1.16) 0.84 (0.61 to 1.15
Gonzalez 725 (207/518) 0.45/0.37 0.925 62/203 104/244 41/71 1.38 (1.09 to 1.74) 1.37 (1.09 to 1.73)
Zabena 255 (75/180) 0.52/0.34 1.0 19/78 34/81 22/21 2.04 (1.38 to 3.02) 2.09 (1.42 to 3.07)
African:
Song_B 1,114 (365/749) 0.47/0.45 0.160 113/239 161/351 91/159 1.09 (0.92 to 1.30) 1.10 (0.92 to 1.31)
South American:
Villalobos 788 (364/424) 0.25/0.17 0.598 209/297 127/114 28/13 1.66 (1.31 to 2.11) 1.7 (1.33 to 2.17)
Mixed:
Willer 19,367 (5,261/14,106) NA NA NA NA NA NA 1.25 (1.19 to 1.31)
Total N (rs9939609) 68,856 (21,132/47,724) Pooled ORs 1.31 (1.25 to 1.37) 1.31 (1.26 to 1.36)
rs1421085
Causian:
Dina_a 3,557 (867/2,690) 0.52/0.41 0.218 200/944 425/1,273 242/473 1.55 (1.39 to 1.73) 1.57 (1.41 to 1.75)
Dina_b 1,678 (699/979) 0.51/0.42 0.896 173/323 334/481 192/175 1.42 (1.24 to 1.63) 1.43 (1.25 to 1.64)
Dina_c 1,001 (482/519) 0.51/0.41 0.205 119/187 233/237 130/95 1.47 (1.24 to 1.75) 1.50 (1.26 to 1.79)
Dina_d 1,018 (504/514) 0.52/0.46 0.051 123/161 235/233 146/120 1.26 (1.07 to 1.49) 1.29 (1.08 to 1.53)
Dina_e 551 (283/268) 0.53/0.40 0.637 62/246 142/343 79/110 1.69 (1.38 to 2.06) 1.67 (1.37 to 2.04)
Peeters 1,367 (1,099/268) 0.48/0.41 0.900 300/93 544/129 255/46 1.31 (1.08 to 1.59) 1.31 (1.09 to 1.59)
Attaoua 248 (119/129) 0.55/0.41 0.585 24/47 58/59 37/23 1.78 (1.24 to 2.54) 1.81 (1.27 to 2.59)
Meyre_FC 1,036 (491/545) 0.49/0.41 0.077 137/197 231/244 123/104 1.31 (1.11 to 1.55) 1.33 (1.12 to 1.59)
Meyre_FA 859 (132/727) 0.51/0.43 0.820 31/238 67/359 34/130 1.42 (1.09 to 1.85) 1.41 (1.09 to 1.84)
Meyre_SA 1,346 (1,028/318) 0.50/0.46 0.055 286/100 460/141 282/77 1.13 (0.96 to 1.34) 1.15 (0.96 to 1.37)
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Page 7 of 15from the USA) and the remaining seven studies were
analyzed (six from France and one from Belgium), the I
2
decreased sharply from 38.1% to 0.0%. Similarly, the
same tendency was found with rs17817449 (data not
shown), suggesting that geographic stratification in an
ethnic subgroup is one of the sources of the between-
study heterogeneity.
We investigated the LD structure of the five SNPs in
all available ethnic populations (Figure 5). We found
that there are substantial differences in the LD struc-
tures in various ethnic populations. Similar ethnic popu-
lations showed similar patterns (Figure 5), including
C E Uw i t hT S I ;Y R I ,M K K ,a n dL W Kw i t hA S W ;a n d
CHB and CHD with JPT. All five SNPs are in strong LD
with each other in Caucasians (Figure 5). For example,
in one Caucasian population, all five SNPs showed
strong LD (r
2 ≥ 0.83), and in this case, rs9939609 may
be selected as a TagSNP for the other four SNPs. Simi-
larly, in three different populations, including Caucasian,
East Asian and Gujarati Indians, four of the five SNPs
(rs9939609, rs8050136, rs1421085, and rs17817449) are
also in strong LD, indicating that rs9939609 can be used
as a TagSNP for the other three SNPs.
Although the five SNPs are in strong LD with each
other in Caucasians, there are obvious differences in the
effect size across the five SNPs: 1.3 (1.24 to 1.37) for
rs9939609, 1.43 (1.33 to 1.53) for rs1421085, 1.41 (1.13
to 1.76) for rs8050136, 1.54 (1.41 to 1.68) for
Table 2 Genotypic distributions and ORs for the association between five polymorphisms and obesity (Continued)
Meyre_GC 1,080 (370/710) 0.55/0.45 0.081 76/227 181/328 113/155 1.47 (1.23 to 1.75) 1.50 (1.25 to 1.79)
Total N (rs1421085) 13,741 (6,074/7,667) Pooled ORs 1.41 (1.31 to 1.51) 1.43 (1.33 to 1.53)
rs8050136
Caucasian:
Hinney 928 (486/442) 0.50/0.39 0.842 123/165 240/212 123/65 1.58 (1.31 to 1.91) 1.59 (1.32 to 1.91)
Grant_C 2,688 (418/2,270) 0.45/0.39 NA NA NA NA NA 1.27 (1.09 to 1.47)
Asian:
Song_AP 240 (77/163) 0.20/0.18 0.425 52/111 20/45 5/7 1.09 (0.68 to 1.73) 1.10 (0.67 to 1.78)
Cheung 1,159 (468/691) 0.16/0.12 0.463 326/535 131/149 11/7 1.48 (1.16 to 1.89) 1.46 (1.15 to 1.85)
Liu 1,180 (278/902) 0.15/0.11 0.489 201/716 73/178 4/8 1.43 (1.08 to 1.91) 1.42 (1.07 to 1.87)
Li 3,210 (398/2,812) NA/0.12 NA NA NA NA 0.91 (0.71 to 1.16) NA
African:
Song_B 1,114 (365/749) 0.42/0.42 0.454 133/257 161/355 71/137 0.98 (0.82 to 1.17) 0.98 (0.82 to 1.17)
Grant_AA 2,002 (578/1,424) 0.45/0.44 NA NA NA NA NA 1.05 (0.91 to 1.21)
Mixed:
Thorleifsson 22,277 (13,785/8,492) NA NA NA NA NA NA 1.27 (1.21 to 1.32)
Total N (rs8050136) 34,798 (16,853/17,945) Pooled ORs 1.22 (0.99 to 1.51) 1.25 (1.13 to 1.38)
rs17817449
Caucasian:
Dina_a [6] 3,548 (873/2,675) 0.49/0.60 0.968 212/948 426/1,288 235/439 1.55 (1.39 to 1.72) 1.55 (1.39 to 1.73)
Dina_b 1,589 (689/900) 0.47/0.59 0.600 164/337 320/489 205/164 1.59 (1.38 to 1.83) 1.60 (1.40 to 1.84)
Dina_c 1,010 (485/525) 0.49/0.60 0.173 120/196 236/237 129/92 1.52 (1.28 to 1.81) 1.55 (1.30 to 1.85)
Dina_d 1,035 (516/519) 0.50/0.55 0.374 138/164 243/246 135/109 1.21 (1.02 to 1.43) 1.22 (1.03 to 1.45)
Dina_e 972 (281/691) 0.46/0.58 0.755 58/231 142/341 81/119 1.65 (1.35 to 2.01) 1.63 (1.34 to 1.99)
Price 1,049 (527/522) 0.49/0.36 0.087 145/205 247/259 135/58 1.72 (1.44 to 2.06) 1.72 (1.44 to 2.05)
Total N (rs17817449) 9,203 (3,371/5,832) Pooled ORs 1.53 (1.40 to 1.67) 1.54 (1.41 to 1.68)
rs1121980
Caucasian:
Hinney 926 (484/442) 0.53/0.41 0.694 104/153 247/218 133/71 1.66 (1.37 to 2.01) 1.64 (1.37 to 1.97)
Renstrom 1,723 (353/1,370) NA NA NA NA NA NA 1.15 (1.05 to 1.25)
Asian:
Hotta 2,451 (927/1,524) 0.26/0.21 0.593 499/947 367/504 61/73 1.32 (1.15 to 1.51) 1.32 (1.16 to 1.51)
Total N (rs1121980) 5,100 (1,764/3,336) Pooled ORs 1.46 (1.17 to 1.83) 1.34 (1.10 to 1.62)
Total Subjects (duplicated subjects were excluded) 112,327 (42,616/69,711)
a: 11, 12, and 22 denote TT, TA, and AA for rs9939609; TT, TC, and CC for rs1421085; CC, CA, and AA for rs8050136; TT, TG, and GG for rs17817449; and GG, GA,
and AA for rs1121980.
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Page 8 of 15rs17819449, and 1.36 (0.96 to 1.92) for rs1121980
(Figures 2, 3, 4). The first four SNPs reported significant
associations, and the last one reported non-significant
associations. On the other hand, the five SNPs are not
in strong LD across all the ethnic groups. Therefore, no
SNP can be treated as tagSNP across all the ethnic
groups. Considering these facts, we showed all the
results concerning all the five SNPs without selection of
tagSNPs. In fact, some studies with very small sample
size were included in this meta-analysis, for example,
only 240 subjects were included in the study by Song et
al. (Song_AP, Table 2). This fact may be one of the rea-
sons for the inconsistent results across the five SNPs in
Caucasians. To address this issue, more studies with lar-
ger sample sizes are needed to provide more precise
evidence.
Figure 2 Forest plot of the association between obesity and the rs9939609 polymorphism under per-allele comparison. On the left, the
name of the first author of the study is followed by the publication year in parentheses. The size of the black box corresponding to each study
is proportional to the sample size, and the horizontal line shows the corresponding 95% CI of the odds ratio (OR). The overall ORs are based on
a random-effects model shown by the diamonds. The solid, vertical line represents the null result.
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Page 9 of 15Figure 3 Forest plot of the association between obesity and the two SNPs under per-allele comparison. On the left, the name of the first
author of the study is followed by the publication year in parentheses. The size of the black box corresponding to each study is proportional to
the sample size, and the horizontal line shows the corresponding 95% CI of the odds ratio (OR). The overall ORs are based on a random-effects
model shown by the diamonds. The solid, vertical line represents the null result. (A) rs1421085; (B) rs8050136.
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Page 10 of 15Figure 4 Forest plot of the association between obesity and the two SNPs under per-allele comparison. On the left, the name of the first
author of the study is followed by the publication year in parentheses. The size of the black box corresponding to each study is proportional to
the sample size, and the horizontal line shows the corresponding 95% CI of the odds ratio (OR). The overall ORs are based on a random-effects
model shown by the diamonds. The solid, vertical line represents the null result. (A) rs17917449; (B) rs1121980.
Peng et al. BMC Medicine 2011, 9:71
http://www.biomedcentral.com/1741-7015/9/71
Page 11 of 15The heterogeneities of all five SNPs are higher in the
meta-analysis. There are many reasons for heterogeneity
in genetic association studies, and these reasons can be
divided into two categories: (1) differential biases due to
population stratification, misclassification of clinical out-
come, differences in BMI, genotyping errors and over-
estimation of genetic effects in the first study and (2)
differences in the pattern of LD structure across popula-
tions [57]. Using sensitivity analyses, we showed that
population stratification may be the reason for higher
heterogeneity in studies focused on rs1421085, indicat-
ing that population stratification can also exist within a
s u b g r o u po ft h es a m ee t h n i c background (Caucasians).
In the meta-regression analysis, a significant association
was detected between the mean control BMI and effect
size on rs9939609, suggesting that the difference in BMI
value between the subjects may also be a source of
heterogeneity.
Analyses of statistical power constitute a crucial step
in the design of genetic association studies. Whereas
conventional statistical power calculations for case-con-
trol studies disregard many basic elements of analytic
complexity and can seriously underestimate true sample
size requirements. Many methods have been proposed
to address the sample size issue in genetic association
study [58-60]. However, owing to many factors, such as
financial pressure, difficulties in sample collection, or
neglect of the importance of sample size, too few sam-
ples were employed in many genetic association studies,
for example, Andreasen_c with total subjects of 377 and
Song_AP with total subjects of 240.
Limitations
Inherent limitations of this meta-analysis should be
pointed out, including the following: (1) Based on the
statistical tests, the heterogeneities are higher in the
Figure 5 LD pattern of the five SNPs obtained from HapMap database ASW. African ancestry in Southwest USA; CEU, Utah residents with
Northern and Western European ancestry from the CEPH collection; CHB, Han Chinese in Beijing, China; CHD, Chinese in Metropolitan Denver,
Colorado; GIH, Gujarati Indians in Houston, Texas; JPT, Japanese in Tokyo, Japan; LWK, Luhya in Webuye, Kenya; MEX, Mexican ancestry in Los
Angeles, California; MKK, Maasai in Kinyawa, Kenya; TSI, Tuscan in Italy; YRI, Yoruban in Ibadan, Nigeria.
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Page 12 of 15results of this meta-analysis. There may be many poten-
tial reasons for the higher heterogeneities, including dif-
ferences in genetic susceptibility across ethnic groups
and measurement error of BMI. (2) Gene-gene and
gene-environment interactions could not be addressed
in this meta-analysis. Actually, obesity is a complex trait,
and many genes are related to obesity [61], such as
MC4R [50,62,63], MAF [50], and NPC1 [50]. On the
other hand, lifestyle factors, including diet and physical
inactivity, are important contributors to weight gain and
obesity [64-66] (3) It may be unreliable to use Begg’s
and Egger’s test as the criteria for publication bias.
Although publication bias was not found, it may exist
due to the fact that some studies with non-significant
associations were not published, and some articles
published in other languages (not English) were not
obtained and included in this meta-analysis [67]. (4)
The Haplotype of the polymorphisms was not per-
formed due to the lack of the related information.
Conclusions
This meta-analysis suggestst h a tF T Om a yr e p r e s e n ta
low-penetrance susceptible gene for obesity risk. Indivi-
dual studies with large sample sizes are needed to further
evaluate the associations between the polymorphisms and
obesity risk in various ethnic populations.
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